|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 801 Pennsylvania Ave., NW Suite 745 |
Address2 |
|
| City | WASHINGTON |
State | DC |
Zip Code | 20004 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 5632-12
|
||||||||
|
6. House ID# 312570000
|
||||||||
| TYPE OF REPORT | 8. Year | 2017 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Brian McCullough |
Date | 4/20/2017 5:42:23 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code AGR
16. Specific lobbying issues
Monitor legislative and administrative action related to pollinator health and habitat promotion.
Monitor legislative and administrative action related to pesticide registration.
Monitor legislative and administrative action related to biotechnology deregulation.
Monitor legislative and administrative action related to genetically modified labeling.
Various issues related to proposed corporate acquisition.
S. 322, Pet and Women Safety Act of 2017.
S. 629, Preventing Antibiotic Resistance Act of 2017.
H.R. 909, Pet and Women Safety Act of 2017.
H.R. 953, Reducing Regulatory Burdens Act of 2017.
H.R. 1029, Pesticide Registration Enhancement Act of 2017.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, White House Office, Agriculture - Dept of (USDA), Environmental Protection Agency (EPA), U.S. Trade Representative (USTR)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Christopher |
Leahy |
|
|
|
Matthew |
Perin |
|
|
|
James |
McVaney |
|
|
|
Ursula |
Wojciechowski |
|
|
|
Edward |
Barron |
|
|
|
Brian |
Nagle |
|
|
|
Lindsay |
Morris |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Monitor legislative and administrative action on appropriations and budget.
S.Con.Res.3, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Christopher |
Leahy |
|
|
|
Brian |
Nagle |
|
|
|
Matthew |
Perin |
|
|
|
James |
McVaney |
|
|
|
Edward |
Barron |
|
|
|
Ursula |
Wojciechowski |
|
|
|
Hallie |
Utley |
|
|
|
Julie |
Corcoran |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CPT
16. Specific lobbying issues
Monitor legislative and administrative action related to intellectual property protection.
17. House(s) of Congress and Federal agencies Check if None
U.S. Trade Representative (USTR)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Christopher |
Leahy |
|
|
|
Brian |
Nagle |
|
|
|
Brian |
McCullough |
|
|
|
Julie |
Corcoran |
|
|
|
Edward |
Barron |
|
|
|
Ursula |
Wojciechowski |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Monitor legislative and administrative action related to health care policy.
Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising.
Monitor legislative and administrative action related to the 340B Drug Pricing Program.
Monitor legislative and administrative action related to access to medical supplies.
Monitor legislative and administration action related to womens health issues.
Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program.
Monitor legislative and administrative action related to over-the-counter consumer care products.
Monitor legislative and administrative action related to dietary supplements.
Monitor legislative and administrative action related to servicing of medical device equipment.
Monitor legislative and administrative action related to companion labeling.
Monitor legislative and administrative action related to FDA monograph reform and user fees.
Monitor legislative and administrative action related to the repeal of the Affordable Care Act.
Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications.
S. 404, A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications.
S. 469, Affordable and Safe Prescription Drug Importation Act.
H.R. 749, Lower Drug Costs through Competition Act.
H.R. 1628, American Health Care Act of 2017.
H.R. 2009, To amend the Federal Food, Drug, and Cosmetic Act to provide clarity with respect to the regulation of diagnostic imaging devices intended for use with contrast agents.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Christopher |
Leahy |
|
|
|
Julie |
Corcoran |
|
|
|
Brian |
Nagle |
|
|
|
Hallie |
Utley |
|
|
|
Lindsay |
Morris |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Monitor legislative and administrative action related to Medicare policy.
Monitor legislative and administrative action related to Medicaid policy.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Christopher |
Leahy |
|
|
|
Julie |
Corcoran |
|
|
|
Brian |
Nagle |
|
|
|
Hallie |
Utley |
|
|
|
Lindsay |
Morris |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAR
16. Specific lobbying issues
Monitor legislative and administrative action related to Miscellaneous Tariff Bill (MTB) petitions.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Christopher |
Leahy |
|
|
|
Brian |
McCullough |
|
|
|
Ursula |
Wojciechowski |
|
|
|
Edward |
Barron |
|
|
|
James |
McVaney |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Monitor legislative and federal activity related to tax reform.
Monitor legislative and federal activity related to Treasury Regulations proposed under section 385 of the Internal Revenue Code.
S. 85, Restoring Access to Medication Act of 2017.
S. 108, Medical Device Access and Innovation Protection Act.
H.R. 184, Protect Medical Innovation Act of 2017.
H.R. 394, Restoring Access to Medication Act of 2017.
H.R. 1268, Veterinary Medicine Loan Repayment Program Enhancement Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Christopher |
Leahy |
|
|
|
Brian |
McCullough |
|
|
|
Ursula |
Wojciechowski |
|
|
|
Hallie |
Utley |
|
|
|
Lindsay |
Morris |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TRD
16. Specific lobbying issues
Monitor legislative issues and administrative action related to trade.
Monitor legislative and administrative action related to Trans-Pacific Partnerships.
Monitor legislative and administrative action related to Transatlantic Trade and Investment Partnership.
Monitor legislative and administrative action related to foreign regulation of chemicals and pesticides.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, U.S. Trade Representative (USTR), Environmental Protection Agency (EPA), Agriculture - Dept of (USDA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Christopher |
Leahy |
|
|
|
Brian |
McCullough |
|
|
|
Ursula |
Wojciechowski |
|
|
|
James |
McVaney |
|
|
|
Julie |
Corcoran |
|
|
|
Lindsay |
Morris |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code GOV
16. Specific lobbying issues
S. 119, Sunshine for Regulatory Decrees and Settlements Act of 2017.
H.R. 469, Sunshine for Regulations and Regulatory Decrees and Settlements Act of 2017.
H.R. 1430, Honest and Open New EPA Science Treatment Act of 2017 or the HONEST Act.
H.R. 1431, EPA Science Advisory Board Reform Act of 2017.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Edward |
Barron |
|
|
|
Chris |
Leahy |
|
|
|
James |
McVaney |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CHM
16. Specific lobbying issues
Monitor legislative issues and administrative action related to the chemical industry.
17. House(s) of Congress and Federal agencies Check if None
Environmental Protection Agency (EPA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Edward |
Barron |
|
|
|
Chris |
Leahy |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |